Intranasal delivery of low-dose insulin ameliorates motor dysfunction and dopaminergic cell death in a 6-OHDA rat model of Parkinson’s Disease

Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial

Dilan Athauda, Kate Maclagan, Simon S. Skene et al. · The Lancet · 2017 · 851 citations · Full text

Medicine, Neurology, Pharmacology +12

Cortical and subcortical lesions impair skilled walking in the ladder rung walking test: a new task to evaluate fore- and hindlimb stepping, placing, and co-ordination

Gerlinde A. S. Metz, Ian Q. Whishaw · Journal of Neuroscience Methods · 2002 · 681 citations

Education, Neurology, Neuroscience +13

Insulin resistance in brain alters dopamine turnover and causes behavioral disorders

André Kleinridders, Weikang Cai, Laura Cappellucci et al. · Proceedings of the National Academy of Sciences · 2015 · 473 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer’s Disease Biomarkers: A Pilot Clinical Trial

Suzanne Craft, Amy Claxton, Laura D. Baker et al. · Journal of Alzheimer s Disease · 2017 · 332 citations · Full text

Medicine, Neurology, Pharmacotherapy +16

Awake Intranasal Insulin Delivery Modifies Protein Complexes and Alters Memory, Anxiety, and Olfactory Behaviors

David Marks, Kristal R. Tucker, Melissa Ann Cavallin et al. · Journal of Neuroscience · 2009 · 240 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17